Anton F. H. Stalenhoef

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Ian D. Graham, Dan Atar, K. Borch‐Johnsen et al. · European Heart Journal · 2007 · 3.8K citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Éric Bruckert, Robert A. Hegele, Jan Albert Kuivenhoven et al. · European Heart Journal · 2014 · 1.1K citations · Full text

Medicine, Cardiology, Genetics +17

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Jacqueline de Graaf, Heidi L.M. Hak-Lemmers, M.P.C. Hectors et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 718 citations

Life Sciences, Biochemistry, Clinical Biochemistry +16

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Philip J. Barter, Christie M. Ballantyne, Rafael Carmena et al. · Journal of Internal Medicine · 2006 · 471 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans

Greetje J. de Grooth, Jan Albert Kuivenhoven, Anton F. H. Stalenhoef et al. · Circulation · 2002 · 455 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17